| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.026 | 0.8 |